Myomesin-2 inhibitors belong to a distinctive class of chemical compounds designed to modulate the activity of the myomesin-2 protein, a critical component of the sarcomeric M-band in muscle cells. Myomesin-2 is a structural protein that plays a crucial role in the organization and stabilization of the sarcomere, the basic contractile unit of muscle tissue. The sarcomere is comprised of various proteins that work in concert to facilitate muscle contraction and relaxation. Myomesin-2, in particular, contributes to the structural integrity of the M-band, providing a scaffold for the assembly of other proteins and maintaining the overall architecture of the sarcomere.
Inhibitors of myomesin-2 function by selectively binding to the active site or specific regions of the protein, thereby impeding its normal physiological functions. By doing so, these inhibitors modulate the interactions between myomesin-2 and its binding partners, disrupting the intricate network of protein-protein interactions within the sarcomere. The design and development of myomesin-2 inhibitors involve a meticulous understanding of the molecular structure and function of the protein, as well as the identification of key binding sites for effective inhibition. As researchers delve deeper into the intricate details of sarcomere biology and the role of myomesin-2, the development of novel inhibitors holds promise for unraveling new insights into muscle physiology and potentially informing strategies for modulating muscle function at the molecular level.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $72.00 $265.00 $495.00 $968.00 | ||
Inhibits myosin II ATPase activity, potentially affecting muscle contraction and indirectly influencing MYOM2 function. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitor, may alter cytoskeletal dynamics affecting the stretch-sensing mechanism where MYOM2 is involved. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
Inhibits myosin light chain kinase, which can impact muscle contraction and thus MYOM2 interaction. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
Calmodulin antagonist, can affect calcium signaling and muscle contraction, indirectly affecting MYOM2. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAP kinase inhibitor, altering the stress response in muscle cells, potentially impacting MYOM2's structural role. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor, affects MAPK/ERK pathway, potentially altering muscle cell function and MYOM2's role within it. | ||||||
Mdivi-1 | 338967-87-6 | sc-215291 sc-215291B sc-215291A sc-215291C | 5 mg 10 mg 25 mg 50 mg | $67.00 $126.00 $251.00 $465.00 | 13 | |
Inhibits mitochondrial fission, which is essential for energy distribution in muscle cells, indirectly affecting MYOM2. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
PKC inhibitor, affecting signal transduction pathways in muscle cells, potentially influencing MYOM2's function. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
Inhibits CaMKII, which may affect calcium signaling and muscle function, indirectly affecting MYOM2. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
Calcium chelator, can disrupt calcium homeostasis and muscle function, possibly impacting MYOM2. | ||||||